MedTrace Logo

Muscle Elastography in Spastic Cerebral Palsy

NCT03112434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2022-04-21

No results posted yet for this study

Summary

To date, clinical tests are unable to differentiate between the cause of muscle stiffness, although a manual instrumented spasticity assessment for the lower limb that utilizes surface electromyogram has recently been proposed. This study intends to use shear wave elastography to assess individual muscle stiffness parameters and the individual response to botulinum toxin injection in the elbow and wrist flexors. Collection of baseline spasticity parameters could then be used to predict the effect of botulinum toxin type A and ultimately serve as a basis for development of a treatment model for muscle spasticity in patients with spastic cerebral palsy.

Conditions

  • Unilateral Spastic Cerebral Palsy

Interventions

DRUG

Botulinum toxin type A

Botox injection in upper extremity for spasticity in pediatric CP patients

Sponsors & Collaborators

  • Radiological Society of North America

    collaborator OTHER

  • Hospital for Special Surgery, New York

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-14
Primary Completion
2020-12-30
Completion
2020-12-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03112434 on ClinicalTrials.gov